He wasn’t the only reporter angry at the NIH. Two Nature journalists retweeted him.
Here’s what happened: By February 3, the Wall Street Journal (WSJ) had a bead on a partnership between the NIH and a group of drug companies to further research, and was ready to publish a story about it. But at 9:54 p.m. on February 3, the NIH sent this email to its press list: Read the rest of this entry »
Yesterday, following a break by the Associated Press (AP), the Guttmacher Institute press office lifted the embargo early on a study showing that abortion rates had fallen to 1970s levels.
From a message sent by the Guttmacher Institute at 4:40 p.m. Eastern, more than seven hours before the scheduled embargo lift at 12:01 a.m.: Read the rest of this entry »
On Thursday, I wrote about a troubling embargo policy at the U.S. Chemical Safety Board (CSB) that forced reporters to agree not to seek outside comment on an investigation report before the embargo lifted, meaning only the CSB’s side of the story would make it into those first pieces.
The U.S. Chemical Safety Board (CSB) released a damning report last night about a fatal 2010 explosion at a Tesoro refinery in Washington State. But to get an embargoed copy of that report to prepare a story, journalists had to agree to some terms that should make most of us uncomfortable.
Here are those terms: Read the rest of this entry »
The Telegraph newspapers will lose access to embargoed content from Nature for a month, with one of their reporters losing that access for three months, following an embargo break earlier today on studies of a newer and faster way to create stem cells.
The story that broke the embargo, written by Sarah Knapton, has was removed temporarily from the newspaper’s site but has now reappeared.
Nature, which lifted the embargo early on the studies ahead of the usual 1 p.m. Eastern embargo, tells us: Read the rest of this entry »
Please note that the embargo on the Journal of Investigative Dermatology paper below is lifted, effective immediately, due to early reporting.
At the time, I wondered whether Welch and the Times would face sanctions. Now we have the answer.
JAMA’s editor-in-chief, Howard Bauchner, tells Embargo Watch: Read the rest of this entry »